Jafron Biomedical (China) Investor Sentiment

300529 Stock   30.48  0.41  1.36%   
About 54% of Jafron Biomedical's investors are presently thinking to get in. The analysis of overall sentiment of trading Jafron Biomedical Co stock suggests that some investors are interested at this time. The current market sentiment, together with Jafron Biomedical's historical and current headlines, can help investors time the market. In addition, many technical investors use Jafron Biomedical stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Jafron BiomedicalLtd Seems To Use Debt Rather Sparingly - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
Should Weakness in Jafron Biomedical Co.,Ltd.s Stock Be Seen As A Sign That Market Will Correct The ...
Google News at Macroaxis
over three months ago at news.google.com         
The three-year shareholder returns and company earnings persist lower as Jafron BiomedicalLtd stock ...
Google News at Macroaxis
over three months ago at news.google.com         
The three-year shareholder returns and company earnings persist lower as Jafron BiomedicalLtd stock ...
Google News at Macroaxis
over three months ago at news.google.com         
Jafron Biomedical Co.,Ltd.s Stock Has Seen Strong Momentum Does That Call For Deeper Study Of Its Fi...
Google News at Macroaxis
over six months ago at news.google.com         
Jafron BiomedicalLtds Dividend Will Be Reduced To CN0.40 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Interested In Jafron BiomedicalLtds Upcoming CN0.40 Dividend You Have Three Days Left - Simply Wall ...
Google News at Macroaxis
over six months ago at news.google.com         
Why Investors Shouldnt Be Surprised By Jafron Biomedical Co.,Ltd.s 30 percent Share Price Surge - Si...
Google News at Macroaxis
over six months ago at news.google.com         
Jafron BiomedicalLtds Soft Earnings Dont Show The Whole Picture - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Jafron BiomedicalLtd First Quarter 2024 Earnings EPS CN0.35 - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Investors Could Be Concerned With Jafron BiomedicalLtds Returns On Capital - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Investors Could Be Concerned With Jafron BiomedicalLtds Returns On Capital - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Jafron Biomedical Co.,Ltd.s PE Is Still On The Mark Following 31 percent Share Price Bounce - Simply...
Google News at Macroaxis
over six months ago at news.google.com         
Fan Dong Jafron Biomedical Co.,Ltd.s CEO is the most bullish insider, and their stock value gained 4...
Google News at Macroaxis
over a year ago at news.google.com         
Disposable Hemoperfusion Device Market Opportunities, Sales, Revenue, Gross Margin Trends Analysis R...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Jafron Biomedical that are available to investors today. That information is available publicly through Jafron media outlets and privately through word of mouth or via Jafron internal channels. However, regardless of the origin, that massive amount of Jafron data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jafron Biomedical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jafron Biomedical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jafron Biomedical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jafron Biomedical alpha.

Jafron Biomedical Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Jafron BiomedicalLtd Seems To Use Debt Rather Sparingly - Simply Wall St
11/22/2024

Complementary Tools for Jafron Stock analysis

When running Jafron Biomedical's price analysis, check to measure Jafron Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jafron Biomedical is operating at the current time. Most of Jafron Biomedical's value examination focuses on studying past and present price action to predict the probability of Jafron Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jafron Biomedical's price. Additionally, you may evaluate how the addition of Jafron Biomedical to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing